Al-Razi Medical Co. announces its Annual Financial results for the period ending on 2025-12-31

31 March 2026 06:58 AM

ALRAZI 9572 0.00% 23.00 0.00

Element List	Current Year	Previous Year	%Change
Sales/Revenue	74,384,311	61,351,419	21.24
Gross Profit (Loss)	19,297,865	16,588,809	16.33
Operational Profit (Loss)	1,574,145	434,609	262.2
Net Profit (Loss) Attributable to Shareholders of the Issuer	819,462	175,867	365.95
Total Comprehensive Income Attributable to Shareholders of the Issuer	879,522	252,468	248.37
Total Shareholders Equity (after Deducting Minority Equity)	23,501,266	22,621,744	3.89
Profit (Loss) per Share	0.54	0.12
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Amount	Percentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value	-	-
All figures are in (Actual) Saudi Arabia, Riyals

Element List	Explanation
The reason of the increase (decrease) in the sales/ revenues during the current year compared to the last year	Revenues: The company achieved an increase in revenues of SAR 13,032,892, representing (21.24%) compared to the previous year, 2024.
The reason of the increase (decrease) in the net profit during the current year compared to the last year is	Net profit: Net profit reached SAR 819,462 during the year 2025, an increase of 365.96%. This increase is attributed to increased sales accompanied by a decrease in operating expenses.
Statement of the type of external auditor's report	Unmodified opinion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion)	nothing
Reclassification of Comparison Items	Certain comparative figures have been reclassified to conform to the presentation of the current year's financial statements.
Additional Information	-
Attached Documents